These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 9083705

  • 1. Acarbose: a review of US clinical experience.
    Coniff R, Krol A.
    Clin Ther; 1997; 19(1):16-26; discussion 2-3. PubMed ID: 9083705
    [Abstract] [Full Text] [Related]

  • 2. Acarbose in NIDDM patients with poor control on conventional oral agents. A 24-week placebo-controlled study.
    Lam KS, Tiu SC, Tsang MW, Ip TP, Tam SC.
    Diabetes Care; 1998 Jul; 21(7):1154-8. PubMed ID: 9653611
    [Abstract] [Full Text] [Related]

  • 3. Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. A placebo-controlled dose-comparison study.
    Coniff RF, Shapiro JA, Robbins D, Kleinfield R, Seaton TB, Beisswenger P, McGill JB.
    Diabetes Care; 1995 Jun; 18(6):817-24. PubMed ID: 7555508
    [Abstract] [Full Text] [Related]

  • 4. Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus.
    Coniff RF, Shapiro JA, Seaton TB, Bray GA.
    Am J Med; 1995 May; 98(5):443-51. PubMed ID: 7733122
    [Abstract] [Full Text] [Related]

  • 5. A risk-benefit appraisal of acarbose in the management of non-insulin-dependent diabetes mellitus.
    Santeusanio F, Compagnucci P.
    Drug Saf; 1994 Dec; 11(6):432-44. PubMed ID: 7727053
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of 24-week monotherapy with acarbose, glibenclamide, or placebo in NIDDM patients. The Essen Study.
    Hoffmann J, Spengler M.
    Diabetes Care; 1994 Jun; 17(6):561-6. PubMed ID: 8082525
    [Abstract] [Full Text] [Related]

  • 7. Acarbose for the treatment of type II diabetes: the results of a Canadian multi-centre trial.
    Josse RG.
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S167-72. PubMed ID: 8529510
    [Abstract] [Full Text] [Related]

  • 8. PROTECT interim results: a large multicenter study of patients with type II diabetes. Precose Resolution of Optimal Titration to Enhance Current Therapies.
    Baron A, Neumann C.
    Clin Ther; 1997 Aug; 19(2):282-95. PubMed ID: 9152567
    [Abstract] [Full Text] [Related]

  • 9. Acarbose in ambulatory treatment of non-insulin-dependent diabetes mellitus associated to imminent sulfonylurea failure: a randomised-multicentric trial in primary health-care. Diabetes and Acarbose Research Group.
    Costa B, Piñol C.
    Diabetes Res Clin Pract; 1997 Oct; 38(1):33-40. PubMed ID: 9347244
    [Abstract] [Full Text] [Related]

  • 10. Clinical experience with acarbose as first line therapy in NIDDM.
    Fölsch UR.
    Clin Invest Med; 1995 Aug; 18(4):312-7. PubMed ID: 8549018
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of acarbose in insulin-treated patients with type 2 diabetes.
    Kelley DE, Bidot P, Freedman Z, Haag B, Podlecki D, Rendell M, Schimel D, Weiss S, Taylor T, Krol A, Magner J.
    Diabetes Care; 1998 Dec; 21(12):2056-61. PubMed ID: 9839094
    [Abstract] [Full Text] [Related]

  • 14. A double-blind placebo-controlled trial evaluating the safety and efficacy of acarbose for the treatment of patients with insulin-requiring type II diabetes.
    Coniff RF, Shapiro JA, Seaton TB, Hoogwerf BJ, Hunt JA.
    Diabetes Care; 1995 Jul; 18(7):928-32. PubMed ID: 7555551
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. An Asian multicenter clinical trial to assess the efficacy and tolerability of acarbose compared with placebo in type 2 diabetic patients previously treated with diet. Asian Acarbose Study Group.
    Chan JC, Chan KW, Ho LL, Fuh MM, Horn LC, Sheaves R, Panelo AA, Kim DK, Embong M.
    Diabetes Care; 1998 Jul; 21(7):1058-61. PubMed ID: 9653595
    [Abstract] [Full Text] [Related]

  • 19. The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.
    Chiasson JL, Josse RG, Hunt JA, Palmason C, Rodger NW, Ross SA, Ryan EA, Tan MH, Wolever TM.
    Ann Intern Med; 1994 Dec 15; 121(12):928-35. PubMed ID: 7734015
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.